Clinical Trial Update: Phase I Study of CS-7017 and Bexarotene [Phase 1]

View source ↗

Summary

Phase I trial of CS-7017 in combination with Bexarotene for solid tumors, lymphoma, and multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma
• Solid Tumors

Drugs mentioned

• Bexarotene (Bexarotene)
• CS-7017

Snippet

Sponsor: Georgetown University | Conditions: Solid Tumors, Lymphoma | Phase 1 | Status: TERMINATED